Cargando…
SEOM-TTCC clinical guideline in nasopharynx cancer (2021)
Nasopharyngeal carcinoma (NPC) is distinct from other cancers of the head and neck in biology, epidemiology, histology, natural history, and response to treatment. Radiotherapy (RT) is the cornerstone of locoregional treatment of non-disseminated disease and the association of chemotherapy improves...
Autores principales: | Rueda Domínguez, Antonio, Cirauqui, Beatriz, García Castaño, Almudena, Alvarez Cabellos, Ruth, Carral Maseda, Alberto, Castelo Fernández, Beatriz, Iglesias Rey, Leticia, Rubió-Casadevall, Jordi, Arrazubi, Virginia, Mesía, Ricard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986714/ https://www.ncbi.nlm.nih.gov/pubmed/35303267 http://dx.doi.org/10.1007/s12094-022-02814-x |
Ejemplares similares
-
SEOM clinical guidelines for the treatment of head and neck cancer (2017)
por: Iglesias Docampo, L. C., et al.
Publicado: (2017) -
SEOM clinical guideline in nasopharynx cancer (2017)
por: Pastor, M., et al.
Publicado: (2017) -
TTCC-2019-02: real-world evidence of first-line cetuximab plus paclitaxel in recurrent or metastatic squamous cell carcinoma of the head and neck
por: Rubió-Casadevall, Jordi, et al.
Publicado: (2023) -
SEOM clinical guidelines for the treatment of head and neck cancer (2020)
por: Mesia, R., et al.
Publicado: (2021) -
SEOM-GEINO clinical guidelines for high-grade gliomas of adulthood (2022)
por: Segura, Pedro Pérez, et al.
Publicado: (2023)